| 19541823 |
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation
Shiotsu, Y,
Kiyoi, H,
Ishikawa, Y,
Tanizaki, R,
Shimizu, M,
Umehara, H,
Ishii, K,
Mori, Y,
Ozeki, K,
Minami, Y,
Abe, A,
Maeda, H,
Akiyama, T,
Kanda, Y,
Sato, Y,
Akinaga, S,
Naoe, T
|
Blood |
2009 |
| 28077790 |
FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors
Nguyen, B,
Williams, AB,
Young, DJ,
Ma, H,
Li, L,
Levis, M,
Brown, P,
Small, D
|
Oncotarget |
2017 |
| 22858906 |
Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors
Williams, AB,
Nguyen, B,
Li, L,
Brown, P,
Levis, M,
Leahy, D,
Small, D
|
Leukemia |
2013 |
